You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon alpha-2

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Phase of Chronic Myeloid Leukemia Trial (Dasatinib, Peg-Interferon alpha2b)

Completed
  • Chronic Phase of Chronic Myeloid Leukemia
  • (no location specified)
Feb 7, 2020

Neuroendocrine Tumors Trial in Besancon, Montbéliard (Metronomic cyclophosphamide, Interferon-alpha)

Completed
  • Neuroendocrine Tumors
  • Besancon, France
  • +1 more
Jul 30, 2021

Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

Recruiting
  • Toxicity, Drug
  • +2 more
  • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

Recruiting
  • Glaucoma, Suspect
  • Aberration, Corneal Wavefront
  • Low dosage selective alpha-2 receptor agonists topical eyedrop
  • High dosage selective alpha-2 receptor agonists topical eyedrop
  • Banhā, QA, Egypt
    Ahmed Abdelshafy
Jan 2, 2023

COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)

Recruiting
  • COVID-19
  • Children
  • Inhaled Interferon α2b
  • Standard of Care
  • Shanghai, China
    Children Hospital of Fudan University
May 18, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Interferon-A-2B, Relapse, Prevention Trial in Beijing (Interferon-alpha)

Withdrawn
  • Interferon-A-2B
  • +3 more
  • Beijing, China
    Peking University People's Hospital
Sep 21, 2020

Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)

Completed
  • Hepatitis C, Chronic
  • Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
  • Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
  • (no location specified)
Aug 24, 2020

Breast Tumors Trial in Guangzhou (IFNa-2a)

Completed
  • Breast Neoplasms
  • Guangzhou, Guangdong, China
    Shicheng Su
Feb 8, 2022

Covid19 Trial in Ankara, Istanbul, Kocaeli (SARS-CoV-2 VLP Vaccine-Wuhan, SARS-CoV-2 VLP Vaccine-Alpha (British) variant,

Completed
  • Covid19
  • SARS-CoV-2 VLP Vaccine-Wuhan
  • +2 more
  • Ankara, Turkey
  • +2 more
May 24, 2022

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)

Completed
Has Results
  • Kidney Cancer
  • recombinant interferon alfa
  • tretinoin liposome
  • New York, New York
  • +1 more
Mar 17, 2022

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Sarcoma, Kaposi, HIV Trial in Puerto Rico, United States (Interferon alfa-2b, Didanosine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Palo Alto, California
  • +12 more
Oct 28, 2021

MDD, Hepatitis C, Chronic Trial in Spain (Escitalopram, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Hepatitis C, Chronic
  • Alcorcon, Spain
  • +14 more
Aug 5, 2020

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Mar 28, 2022

HIV Trial in United States (Interferon alfa-n3, Interferon alfa-n1)

Completed
  • HIV Infections
  • Interferon alfa-n3
  • Interferon alfa-n1
  • Los Angeles, California
  • +14 more
Oct 27, 2021

Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)

Not yet recruiting
  • Coronary Artery Disease
  • BioMatrix Alpha
  • Birmingham, United Kingdom
  • +5 more
Mar 23, 2023

Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial

Completed
Has Results
  • Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
  • +2 more
  • DC vaccine
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 6, 2020

Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 400 mg, Imatinib mesylate 600 mg, Imatinib 400 mg +

Completed
  • Chronic Myeloid Leukemia
  • Imatinib mesylate 400 mg
  • +3 more
  • Poitiers, France
    University Hospital
Apr 10, 2020

Leukemia Trial in Philadelphia (Interferon alpha-2B (IFN-a) 3 million units (MU) subcutaneous daily)

Completed
  • Leukemia
  • Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 20, 2020

Breast Carcinoma Trial in Houston (biological, drug, other)

Not yet recruiting
  • Breast Carcinoma
  • eftilagimod alpha
  • +2 more
  • Houston, Texas
    Oncology Consultants
Feb 17, 2023

HIV Trial in United States (Interferon alfa-2a, Zidovudine, Zalcitabine)

Completed
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021